Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.

Oncology reports - 1 Aug 2005

Roncuzzi Laura, Brognara Irene, Baiocchi Daniela, Amadori Dino, Gasperi-Campani Anna

Abstract excerpt

Genetic alterations on chromosome 17p are frequent in a variety of human malignancies such as sporadic breast carcinomas. The clinico-pathological significance of it remains to be elucidated. The purpose of this study was to explore whether the allelic loss (LOH) in 17p13.3, which is suggested by the presence of tumour suppressor genes, independent of TP53, are related to current clinico-pathological criteria for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 17
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Polymorphism, Single-Stranded Conformational

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Telomere

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 16012732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.PMID 16012732Read ↗

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.Semantic proximity Read ↗

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.Semantic proximity Read ↗

Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.Semantic proximity Read ↗

Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.Semantic proximity Read ↗

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.Semantic proximity Read ↗

Deletion of 17p in cancers: Guilt by (p53) associationSemantic proximity Read ↗

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.Semantic proximity Read ↗

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.Semantic proximity Read ↗

Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.Semantic proximity Read ↗

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.Semantic proximity Read ↗

Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.Semantic proximity Read ↗

Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.